Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 899 of 1,261
  1. US 8309070

    Use of umbilical cord blood stem cells to treat ischemic event

    Regents of the University of Minnesota · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  2. US 8309071

    Foamy viral envelope genes

    Vectoria Forschungsforderungs Verein E.V. · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  3. US 8309566

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Rigel Pharmaceuticals, Inc. · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  4. US 8309355

    Methods of treating Parkinson's disease using viral vectors

    The Regents of the University of California · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  5. US 8309543

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  6. US 8309680

    Segmented degradable polymers and conjugates made therefrom

    Nektar Therapeutics · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  7. US 8309701

    Variants of human taste receptor genes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  8. US 8304408

    Wnt signaling inhibitors, and methods for making and using them

    The Regents of the University of California · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  9. US 8303960

    Radiolabeled affibody molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  10. US 8303984

    Skin treatment compositions containing copper-pigment complexes

    Discovery Limited · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  11. US 8303985

    Skin treatment compositions containing copper-pigment complexes

    Discovery Limited · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  12. US 8303995

    Nitrite formulations and their use as nitric oxide prodrugs

    The Board of Regents of the University of Texas System · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  13. US 8304247

    Recognitive hydrogel

    The Board of Regents of the University of Texas System · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  14. US 8304397

    Identification of a micro-RNA that activates expression of β-myosin heavy chain

    The Board of Regents of the University of Texas System · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  15. US 8304399

    Hedgehog signaling pathway proteins and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  16. US 8304385

    Macrocyclic tetrazolyl hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  17. US 8304414

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  18. US 8304511

    Maleamic acid polymer derivatives and their bioconjugates

    Nektar Therapeutics · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  19. US 8304577

    Modulators of G protein-coupled receptor 88

    LEXICON PHARMACEUTICALS, INC. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  20. US 8304432

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  21. US 8304428

    Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

    Infinity Discovery, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  22. US 8304423

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  23. US 8304433

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Theravance, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  24. US 8304422

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.